(Q61933731)
Statements
An Open-label Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics/Pharmacodynamics and Safety of GK Activator (2) Following a Single Oral Dose Administration in Patients With Type 2 Diabetes. (English)
0 references
January 2006
0 references
August 2007
0 references
5
0 references
18 year
0 references
75 year
0 references